14-3-3 protein

14 - 3 - 3 蛋白
  • 文章类型: Journal Article
    二萜葡糖苷fusicocin-A(FC-A)是一种真菌植物毒素,可通过形成稳定的三元复合物来稳定植物14-3-3蛋白与质膜H-ATPase的相互作用。先前的研究表明,结构修饰的FC-A衍生物具有显著的抗肿瘤活性,但它们的合成涉及爆炸性试剂,限制了它们的效用和进一步的结构-活动-关系研究的机会。在这项研究中,我们通过在fusicocan支架和葡萄糖苷部分上引入各种取代基合成了一系列FC衍生物,并评估了它们对14-3-3与荧光标记的模式1和模式3磷酸肽结合的稳定作用。结果表明,在葡糖苷部分的6'-位引入氨基改善了稳定性。此外,基于细胞的评估表明,6'-氨基苄基21b比以前开发的FC药物具有更高的抗增殖活性。
    The diterpene glucoside fusicoccin-A (FC-A) is a fungal phytotoxin that stabilizes the interaction of plant 14-3-3 protein and plasma membrane H+-ATPase by forming a stable ternary complex. Previous studies demonstrated that structurally modified FC-A derivatives exhibit significant antitumor activities but their synthesis involves an explosive reagent, limiting their utility and opportunities for further structure-activity-relationship studies. In this study, we synthesized a series of FC derivatives by introducing various substituents on the fusicoccan scaffold and on the glucoside moiety, and evaluated their stabilization effects on the binding of 14-3-3 to fluorescently labeled mode-1 and mode-3 phosphopeptides. The results showed that introducing an amino group at the 6\'-position of the glucoside moiety improves stabilization. Furthermore, cell-based evaluation demonstrated that 6\'-amino benzyl 21b exhibits higher antiproliferative activity than previously developed FC agents.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    BACKGROUND: Creutzfeldt-Jakob disease (CJD) is a progressive, fatal, neurodegenerative disease classified under transmissible spongiform encephalopathies (TSE) or prion diseases. It is characterized by long asymptomatic period followed by rapid clinical deterioration leading to the death within months. The disease is still under-reported in India.
    OBJECTIVE: The aim of this study was to describe the clinical, radiological and electroencephalographic characteristics of eight cases of CJD encountered in MS Ramaiah Medical college and Hospital, Bangalore over the past 3 years (2010-2013). This was retrospective, observational, hospital-based study.
    RESULTS: The mean age of patients was 66.6 years (range: 54-82) and there was female predominance (five patients). The main clinical manifestations were cognitive disturbance (8/8) and myoclonus (8/8), followed by behavioral disturbance (5/8), ataxia (5/8) and extra-pyramidal symptoms/signs (4/8). Time interval (mean) between onset of disease to death was 6.6 months (range: 3-14). Brain MRI abnormalities were noted in 6 patients: Fluid-attenuated inversion recovery hyperintensities with restriction on diffusion-weighted image/apparent diffusion coefficient (DWI/ADC) in caudate and putamen, and diffusion hyperintensities without restriction on ADC in parieto-occipital, frontal and temporal regions. Classical electroencephalogram (EEG) changes of periodic triphasic waves were seen in 87% of patients. The CSF 14-3-3 protein assay was positive in two patients (out of four). Seven cases were probable CJD and one was possible CJD.
    CONCLUSIONS: A strong clinical suspicion aided by characteristic brain MRI and EEG abnormalities is essential for timely diagnosis of this fatal disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号